Nya klassifikationskriterier för antifosfolipidsyndrom
(2025) In Lakartidningen 122. p.1-4- Abstract
The new ACR/EULAR classification criteria for APS differ from the previous Sydney criteria by incorporating a broader range of clinical manifestations beyond venous/arterial thromboembolism and obstetric complications. These include microvascular disease, heart valve disease and thrombocytopenia. We applied both classification systems to a cohort of 139 individuals diagnosed with primary APS in Southern Sweden. Of these, 76 met the ACR/EULAR criteria, while 78 fulfilled the Sydney criteria. Subsequently, only a marginal difference in diagnostic yield was observed between the two classification systems. However, the ACR/EULAR criteria are particularly advantageous as they provide clear definitions and encompass a broader spectrum of... (More)
The new ACR/EULAR classification criteria for APS differ from the previous Sydney criteria by incorporating a broader range of clinical manifestations beyond venous/arterial thromboembolism and obstetric complications. These include microvascular disease, heart valve disease and thrombocytopenia. We applied both classification systems to a cohort of 139 individuals diagnosed with primary APS in Southern Sweden. Of these, 76 met the ACR/EULAR criteria, while 78 fulfilled the Sydney criteria. Subsequently, only a marginal difference in diagnostic yield was observed between the two classification systems. However, the ACR/EULAR criteria are particularly advantageous as they provide clear definitions and encompass a broader spectrum of clinical manifestations, aligning more closely with the clinical management of patients with APS compared to the Sydney criteria.
(Less)
- author
- Hasani, Liridon
LU
; Olin, Signe
LU
; Bengtsson, Anders LU ; Jönsen, Andreas LU ; Ohlsson, Sophie LU
; Elf, Johan LU ; Strevens, Helena LU and Zetterberg, Eva LU
- organization
- alternative title
- New classification criteria for antiphospholipid syndrome : implications and clinical significance
- publishing date
- 2025-09-17
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Humans, Antiphospholipid Syndrome/classification, Female, Adult, Male, Middle Aged, Pregnancy, Clinical Relevance
- in
- Lakartidningen
- volume
- 122
- article number
- 24149
- pages
- 1 - 4
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:40960363
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- 0baa87a0-4f31-454a-b2e4-b20e5aed1aad
- alternative location
- https://media.arto.se/app/uploads/sites/11/2025/09/09132330/24149.pdf
- date added to LUP
- 2025-09-23 00:56:38
- date last changed
- 2025-09-23 07:25:39
@article{0baa87a0-4f31-454a-b2e4-b20e5aed1aad, abstract = {{<p>The new ACR/EULAR classification criteria for APS differ from the previous Sydney criteria by incorporating a broader range of clinical manifestations beyond venous/arterial thromboembolism and obstetric complications. These include microvascular disease, heart valve disease and thrombocytopenia. We applied both classification systems to a cohort of 139 individuals diagnosed with primary APS in Southern Sweden. Of these, 76 met the ACR/EULAR criteria, while 78 fulfilled the Sydney criteria. Subsequently, only a marginal difference in diagnostic yield was observed between the two classification systems. However, the ACR/EULAR criteria are particularly advantageous as they provide clear definitions and encompass a broader spectrum of clinical manifestations, aligning more closely with the clinical management of patients with APS compared to the Sydney criteria.</p>}}, author = {{Hasani, Liridon and Olin, Signe and Bengtsson, Anders and Jönsen, Andreas and Ohlsson, Sophie and Elf, Johan and Strevens, Helena and Zetterberg, Eva}}, issn = {{0023-7205}}, keywords = {{Humans; Antiphospholipid Syndrome/classification; Female; Adult; Male; Middle Aged; Pregnancy; Clinical Relevance}}, language = {{swe}}, month = {{09}}, pages = {{1--4}}, publisher = {{Swedish Medical Association}}, series = {{Lakartidningen}}, title = {{Nya klassifikationskriterier för antifosfolipidsyndrom}}, url = {{https://media.arto.se/app/uploads/sites/11/2025/09/09132330/24149.pdf}}, volume = {{122}}, year = {{2025}}, }